Vaishali Pharma Stock Screener | Share Price & Fundamental Analysis
VAISHALI
Pharmaceuticals
Screen Vaishali Pharma share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹9.03
▼
-0.40 (-4.24%)
Market Cap
₹99.58 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.83
EPS (TTM)
₹0.06
Dividend Yield
-
Debt to Equity
0.24
52W High
₹17.91
52W Low
₹7.90
Operating Margin
6.00%
Profit Margin
4.00%
Revenue (TTM)
₹25.00
EBITDA
₹2.00
Net Income
₹1.00
Total Assets
₹110.00
Total Equity
₹65.00
Vaishali Pharma Share Price History - Stock Screener Chart
Screen VAISHALI historical share price movements with interactive charts. Analyze price trends and patterns.
Vaishali Pharma Company Profile - Fundamental Screener
Screen Vaishali Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VAISHALI shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE972X01022
Vaishali Pharma Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen VAISHALI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 110 | 80 | 79 | 82 | 86 | 66 | 69 | 64 | 45 |
| Current Assets | 105 | 75 | 73 | 76 | 81 | 61 | 63 | 59 | 40 |
| Fixed Assets | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| Liabilities | |||||||||
| Total Liabilities | 110 | 80 | 79 | 82 | 86 | 66 | 69 | 64 | 45 |
| Current Liabilities | 5 | 4 | 6 | 3 | 4 | 4 | 5 | 3 | 4 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 65 | 43 | 41 | 26 | 22 | 21 | 21 | 21 | 4 |
| Share Capital | 26 | 11 | 11 | 11 | 11 | 11 | 7 | 7 | 3 |
| Reserves & Surplus | 39 | 32 | 30 | 16 | 12 | 11 | 15 | 14 | 1 |
Screen VAISHALI income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Jun | 2025-Sept |
|---|---|---|
| Revenue | 25 | 34 |
| Expenses | 22 | 32 |
| EBITDA | 2 | 2 |
| Operating Profit % | 6.00% | 4.00% |
| Depreciation | 0 | 0 |
| Interest | 0 | 0 |
| Profit Before Tax | 2 | 2 |
| Tax | 1 | 1 |
| Net Profit | 1 | 1 |
| EPS | 0.10 | 0.09 |
Vaishali Pharma Cash Flow Screener - Liquidity Fundamentals
Screen VAISHALI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -18 | 1 | 1 | 1 | 2 | 3 | 4 | -10 | 1 | 5 |
| Investing Activities | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 1 | 3 |
| Financing Activities | 19 | -1 | -2 | 0 | -2 | -3 | -4 | 9 | -1 | -8 |
| Net Cash Flow | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen VAISHALI shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-May | 2024-Jun | 2024-Jul | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 26.32% | 26.32% | 26.32% | 26.32% | 24.87% | 26.32% | 31.61% | 26.32% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 65.24% | 65.88% | 67.25% | 62.93% | 66.66% | 66.11% | 62.17% | 64.98% |
| Other Holding | 8.44% | 7.80% | 6.43% | 10.74% | 8.46% | 7.57% | 6.22% | 8.70% |
| Shareholder Count | 28,874 | 28,682 | 27,752 | 9,390 | 10,296 | 9,479 | 9,479 | 18,983 |
Vaishali Pharma Dividend Screener - Share Yield Analysis
Screen VAISHALI dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Vaishali Pharma Index Membership - Market Screener Classification
Screen VAISHALI by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Vaishali Pharma Market Events Screener - Corporate Actions
Screen VAISHALI market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 19.02% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -1.85% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -4.93% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.61% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 4.37% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.12% |
| 2024-10-15 | 2024-10-15 | Bonus | 1:1 | -2.49% |
| 2024-10-15 | 2024-08-28 | Split | 2:10 | 0.00% |
| 2019-10-17 | Bonus | 3:5 | - |
Vaishali Pharma Competitors Screener - Peer Comparison
Screen VAISHALI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Vaishali Pharma Company Announcements - News Screener
Screen VAISHALI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-09 | General Updates | View |
| 2025-11-17 | Copy of Newspaper Publication | View |
| 2025-11-14 | Outcome of Board Meeting | View |
| 2025-11-14 | Outcome of Board Meeting | View |
| 2025-10-14 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | View |
| 2025-10-14 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | View |
| 2025-09-23 | Change in Management | View |
| 2025-09-23 | Shareholders meeting | View |